Anuradha Choughule
Overview
Explore the profile of Anuradha Choughule including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
104
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khuntia S, Mukherjee N, Javle V, Tanwar N, Sreekanthreddy P, Varghese L, et al.
JCO Glob Oncol
. 2024 Nov;
10:e2400289.
PMID: 39571115
Purpose: Gene fusions are critical oncogenic mutations that drive cancer development and serve as diagnostic and prognostic biomarkers. Despite the increasing cancer burden in India, large-scale analyses of molecular landscapes,...
2.
Tanwar N, Malhotra R, Satheesh A, Khuntia S, Sreekanthreddy P, Varghese L, et al.
JCO Glob Oncol
. 2023 Dec;
9:e2300047.
PMID: 38085046
Purpose: The purpose of this study was to understand the impact of population diversity and geographic variation on tumor mutation burden (TMB) scores across cancers and its implication on stratification...
3.
Trivedi V, Noronha V, Sreekanthreddy P, Desai S, Poojary D, Varghese L, et al.
Front Endocrinol (Lausanne)
. 2023 Nov;
14:1152514.
PMID: 38027096
Introduction: The diverse subtypes of thyroid carcinoma have distinct clinical outcomes despite a comparable spectrum of underlying genetic alterations. Beyond genetic alterations, sparse efforts have been made to characterize the...
4.
Burikhanov R, Ganguly S, Ellingson S, Sviripa V, Araujo N, Li S, et al.
Am J Cancer Res
. 2023 Apr;
13(3):976-991.
PMID: 37034206
Lung cancer is the leading cause of cancer-related deaths. Lung cancer cells develop resistance to apoptosis by suppressing the secretion of the tumor suppressor Par-4 protein (also known as PAWR)...
5.
Bondili S, Nandhana R, Dhanawat A, Noronha V, Joshi A, Patil V, et al.
Ecancermedicalscience
. 2022 Oct;
16:1438.
PMID: 36200011
Background: Pulmonary sarcomatoid carcinoma (PSC) constitutes a heterogeneous group of poorly differentiated non-small cell lung cancers. Since these are rare tumours, we sought to determine the characteristics and clinical outcomes...
6.
Behel V, Noronha V, Choughule A, Shetty O, Chandrani P, Kapoor A, et al.
JCO Glob Oncol
. 2022 Jul;
8:e2200030.
PMID: 35802838
Purpose: Multidisciplinary molecular tumor boards (MTBs) help in interpreting complex genomic data generated by molecular tumor profiling and improve patients' access to targeted therapies. The purpose of this study was...
7.
Joshi A, Butle A, Hait S, Mishra R, Trivedi V, Thorat R, et al.
Transl Oncol
. 2022 Jun;
22:101461.
PMID: 35653897
Osimertinib, a third-generation EGFR tyrosine kinase inhibitor, shows significant benefit among patients with EGFR T790M mutation at disease progression. We analyzed the whole exome sequence of 48 samples obtained from...
8.
Joshi A, Mishra R, Desai S, Chandrani P, Kore H, Sunder R, et al.
Oncotarget
. 2021 Apr;
12(6):578-588.
PMID: 33796225
Introduction: Unlike lung adenocarcinoma patients, there is no FDA-approved targeted-therapy likely to benefit lung squamous cell carcinoma patients. Materials And Methods: We performed survival analyses of lung squamous cell carcinoma...
9.
Kumar Singh G, Bajpai J, Joshi S, Prabhash K, Choughule A, Patil A, et al.
Ecancermedicalscience
. 2020 Oct;
14:1092.
PMID: 33014134
Triple negative breast carcinoma is a problematic subtype with poor outcomes. Many clinical trials are underway to find possible target to increase treatment options. Epidermal growth factor receptor (EGFR) has...
10.
Iyer P, Shrikhande S, Ranjan M, Joshi A, Gardi N, Prasad R, et al.
Int J Cancer
. 2018 Oct;
144(8):2008-2019.
PMID: 30304546
The uncommonness of gallbladder cancer in the developed world has contributed to the generally poor understanding of the disease. Our integrated analysis of whole exome sequencing, copy number alterations, immunohistochemical,...